Latest immunotherapy news
Immunochemotherapy Infusions Early in the Day Tied to Improved NSCLC Survival
posted February 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Quadruplet Regimen for Adults With Newly Diagnosed Multiple Myeloma
posted February 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Presurgical Pembrolizumab Beneficial for Desmoplastic Melanoma
posted February 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
One Year of Abatacept Delays Progression to RA for Up to Four Years in At-Risk Population
posted January 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL 
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported 
Updated COVID-19 Shot Beneficial for Those With Autoimmune Rheumatic Disease Related Articles
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors 
Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer 
Omalizumab, Multiallergen OIT Both Viable for Multifood Allergy Treatment Monthly Specialist Briefings
Stay Connected
